Showing 1 - 10 of 11
Managing Covid drugs
Oped, Editorial, Published on 01/04/2022
» Record Covid cases and ongoing reports of sluggish management of Covid medicine stock might derail the government's ambitious plans to list Covid-19 as endemic on July 1.
Test kit snags worsen
Oped, Editorial, Published on 20/01/2022
» The threat posed by the highly transmissible Omicron coronavirus variant makes rapid testing more than necessary. Yet the high prices of test kits and shortage of supply have made containing the pandemic that much harder.
Review antiviral plan
News, Editorial, Published on 11/10/2021
» It is a harsh reality that Covid-19 could linger for years with vaccines to tackle it neither highly effective against new variants nor accessible to everyone. The world therefore is throwing its weight behind research and development of antiviral drugs.
New test kit mystery
Oped, Editorial, Published on 08/10/2021
» Antigen test kits (ATK), used in detection of the coronavirus, are now more than just a medical device; they are also the latest strategic tool for reopening business and activities.
GPO must act fast on ATKs
Oped, Editorial, Published on 25/08/2021
» The cabinet motion yesterday on the problematic procurement of home-use rapid antigen test kits (ATKs) proves one thing. The prime minister -- who has crafted thirty articles of legislation relating to Covid with his own hands since March -- cannot use his power and leadership to defuse the conflict that has erupted at a time when society needs his guidance the most.
Slow to learn Covid lessons
News, Editorial, Published on 23/08/2021
» When Thailand reached the grim milestone of more than one million accumulated Covid-19 infection cases on Friday, some thought the government might have learnt some lessons and gained experience from the Covid crisis.
Covid self-test kit woes
Oped, Editorial, Published on 13/08/2021
» The Ministry of Public Health has made the right move with its policy of providing 8.5 million free Covid antigen self-testing kits to the public. The kits offer some hope for efforts to contain the pandemic. They will enable early detection and timely treatment -- keys to reducing serious illness while protecting the healthcare system from collapsing.
Act now on favipiravir
Oped, Editorial, Published on 04/08/2021
» Access to medicine can make a life-and-death difference amid the Covid-19 emergency. The government cannot afford to fail in the crucial mission of securing enough of the antiviral medication favipiravir to cover the rapid increase of patients.
A failure to communicate
Oped, Editorial, Published on 17/07/2021
» In a time when society needs unity to overcome the pandemic, it's dispiriting to see the Governmental Pharmaceutical Organization (GPO) filing a libel lawsuit against Thonburi Healthcare Group (THG) chairman Boon Vanasin, who recently voiced his frustration about the slow pace of vaccine imports, a reaction related to his group's vaccine procurement having to go through state agencies.
Public needs antiviral meds
Oped, Editorial, Published on 01/05/2021
» Amid the Covid-19 pandemic, Thais have been gripped by fear. For months, these worries -- which have been intensified during the kingdom's third wave of infections -- have been about the government's slow vaccination rollout. Now the public is getting more anxious, following concerns over a possible shortage of favipiravir, an important medicine used to treat Covid-19 patients with moderate to severe symptoms.